<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) has one of the highest incidences among <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The majority of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> are <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> that occur in individuals without family histories of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> or inherited mutations </plain></SENT>
<SENT sid="2" pm="."><plain>Unfortunately, whole-genome expression studies of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> are limited </plain></SENT>
<SENT sid="3" pm="."><plain>A recent study used microarray techniques to identify a predictor gene set indicative of susceptibility to early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>However, the molecular mechanisms of the predictor gene set were not fully investigated in the previous study </plain></SENT>
<SENT sid="5" pm="."><plain>To understand the functional roles of the predictor gene set, in the present study we applied a subpathway-based statistical model to the microarray data from the previous study and identified mechanisms that are reasonably associated with the predictor gene set </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, significant subpathways belonging to 2 KEGG pathways (focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>; natural killer cell-mediated cytotoxicity) were found to be involved in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>We also showed that the 2 pathways were functionally involved in the predictor gene set using a text-mining technique </plain></SENT>
<SENT sid="8" pm="."><plain>Entry of a single member of the predictor gene set triggered a focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> pathway, which confers anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, intensive inspection of the predictor gene set in terms of the 2 pathways suggested that some entries of the predictor gene set were implicated in immunosuppression along with epithelial-mesenchymal transition (EMT) in the early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, we compared our subpathway-based statistical model with a gene set-based statistical model, <z:chebi fb="75" ids="27847,53620">MIT</z:chebi> Gene Set Enrichment Analysis (GSEA) </plain></SENT>
<SENT sid="11" pm="."><plain>Our method showed better performance than GSEA in the sense that our method was more consistent with a well-known <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related pathway set </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, the biological suggestion generated by our subpathway-based approach seems quite reasonable and warrants a further experimental study on early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in terms of <z:e sem="disease" ids="C0002793" disease_type="Neoplastic Process" abbrv="">dedifferentiation</z:e> or differentiation, which is underscored in EMT and immunosuppression </plain></SENT>
</text></document>